These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9521079)

  • 1. Dendritic cells, but not macrophages, produce IL-12 immediately following Leishmania donovani infection.
    Gorak PM; Engwerda CR; Kaye PM
    Eur J Immunol; 1998 Feb; 28(2):687-95. PubMed ID: 9521079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen.
    Basu A; Chakrabarti G; Saha A; Bandyopadhyay S
    Immunology; 2000 Feb; 99(2):305-13. PubMed ID: 10692051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization of IL-12 demonstrates the existence of discrete organ-specific phases in the control of Leishmania donovani.
    Engwerda CR; Murphy ML; Cotterell SE; Smelt SC; Kaye PM
    Eur J Immunol; 1998 Feb; 28(2):669-80. PubMed ID: 9521077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetically Modified Live Attenuated Leishmania donovani Parasites Induce Innate Immunity through Classical Activation of Macrophages That Direct the Th1 Response in Mice.
    Bhattacharya P; Dey R; Dagur PK; Kruhlak M; Ismail N; Debrabant A; Joshi AB; Akue A; Kukuruga M; Takeda K; Selvapandiyan A; McCoy JP; Nakhasi HL
    Infect Immun; 2015 Oct; 83(10):3800-15. PubMed ID: 26169275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.
    Reiner NE; Ng W; Wilson CB; McMaster WR; Burchett SK
    J Clin Invest; 1990 Jun; 85(6):1914-24. PubMed ID: 2112157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice.
    Lehmann J; Enssle KH; Lehmann I; Emmendörfer A; Lohmann-Matthes ML
    J Interferon Cytokine Res; 2000 Jan; 20(1):63-77. PubMed ID: 10670653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TLR-mediated distinct IFN-γ/IL-10 pattern induces protective immunity against murine visceral leishmaniasis.
    Paul J; Karmakar S; De T
    Eur J Immunol; 2012 Aug; 42(8):2087-99. PubMed ID: 22622993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection.
    Maroof A; Kaye PM
    Infect Immun; 2008 Jan; 76(1):239-49. PubMed ID: 17998312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania donovani: evolution and architecture of the splenic cellular immune response related to control of infection.
    Melby PC; Tabares A; Restrepo BI; Cardona AE; McGuff HS; Teale JM
    Exp Parasitol; 2001 Sep; 99(1):17-25. PubMed ID: 11708830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs.
    Schleicher U; Liese J; Knippertz I; Kurzmann C; Hesse A; Heit A; Fischer JA; Weiss S; Kalinke U; Kunz S; Bogdan C
    J Exp Med; 2007 Apr; 204(4):893-906. PubMed ID: 17389237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vivo analysis of cytokine production during Leishmania donovani infection in scid mice.
    Engwerda CR; Smelt SC; Kaye PM
    Exp Parasitol; 1996 Nov; 84(2):195-202. PubMed ID: 8932769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection.
    Ahuja SS; Reddick RL; Sato N; Montalbo E; Kostecki V; Zhao W; Dolan MJ; Melby PC; Ahuja SK
    J Immunol; 1999 Oct; 163(7):3890-7. PubMed ID: 10490989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular therapy by allogeneic macrophages against visceral leishmaniasis: role of TNF-α.
    Manna PP; Hira SK; Basu A; Bandyopadhyay S
    Cell Immunol; 2014 Jul; 290(1):152-63. PubMed ID: 24996013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE
    J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells.
    Stäger S; Maroof A; Zubairi S; Sanos SL; Kopf M; Kaye PM
    Eur J Immunol; 2006 Jul; 36(7):1764-71. PubMed ID: 16791879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania donovani: CD2 biased immune response skews the SAG mediated therapy for a predominant Th1 response in experimental infection.
    Bimal S; Sinha S; Singh SK; Narayan S; Kumar V; Verma N; Ranjan A; Sinha PK; Das VN; Pandey K; Kar SK; Das P
    Exp Parasitol; 2012 Jul; 131(3):274-82. PubMed ID: 22580024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania donovani targets tumor necrosis factor receptor-associated factor (TRAF) 3 for impairing TLR4-mediated host response.
    Gupta P; Giri J; Srivastav S; Chande AG; Mukhopadhyaya R; Das PK; Ukil A
    FASEB J; 2014 Apr; 28(4):1756-68. PubMed ID: 24391131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice.
    Carrera L; Gazzinelli RT; Badolato R; Hieny S; Muller W; Kuhn R; Sacks DL
    J Exp Med; 1996 Feb; 183(2):515-26. PubMed ID: 8627163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.